CMEDEarnings•prnewswire•
CalciMedica Reports Second Quarter 2025 Financial Results and Provides Clinical & Corporate Updates
Sentiment:Negative (30)
Summary
Enrollment ongoing in Phase 2 KOURAGE trial of Auxora™ in acute kidney injury (AKI) with respiratory failure; data expected in early 2026 Productive initial meeting with the FDA on Auxora in acute pancreatitis (AP); conversations continue, with alignment on a pivotal trial anticipated...
Original Article
Read the full article from the original source for complete details and context.
Read Full ArticleArticle published on August 12, 2025 by prnewswire